04:42 PM EDT, 08/22/2025 (MT Newswires) -- Andrew S Boyer, Executive Vice President, on August 20, 2025, sold 279,244 shares in Amneal Pharmaceuticals ( AMRX ) for $2,619,309. Following the Form 4 filing with the SEC, Boyer has control over a total of 152,426 Class A common shares of the company, with 152,426 shares held directly.
SEC Filing:
https://www.sec.gov/Archives/edgar/data/1723128/000162828025041033/xslF345X05/wk-form4_1755895080.xml